Literature DB >> 17724816

Positron emission tomography/computed tomography with (18)F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma.

Long Sun1, Hua Wu, Wei-Ming Pan, Yong-Song Guan.   

Abstract

Patients suffering from hepatocellular carcinoma (HCC) with tumor thrombus in the portal vein generally have a poor prognosis. Portal vein tumor thrombus must be distinguished from portal vein blood thrombus, and this identification plays a very important role in management of HCC. Conventional imaging modalities have limitations in discrimination of portal vein tumor thrombus. The application of positron emission tomography (PET) with (18)F-fluorodeoxyglucose ((18)F-FDG) for discrimination between tumor extension and blood thrombus has been reported in few cases of HCC, while portal tumor thrombosis and portal vein clot identified by (18)F-FDG PET/CT in HCC patients has not been reported so far. We present two HCC cases, one with portal vein tumor thrombus and one thrombosis who were identified with (18)F-FDG PET/CT. This report illustrates the complimentary value of combining the morphological and functional imaging in achieving a correct diagnosis in such clinical situations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17724816      PMCID: PMC4611593          DOI: 10.3748/wjg.v13.i33.4529

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  12 in total

1.  Hepatocellular carcinoma tumour thrombus in a re-canalised para-umbilical vein: detection by 18-fluoro-2-deoxyglucose positron emission tomography imaging.

Authors:  C J Beadsmoore; H K Cheow; E Sala; D J Lomas; P Gibbs; V Save; M E D Alison; K K Balan
Journal:  Br J Radiol       Date:  2005-09       Impact factor: 3.039

2.  18F-FDG PET for hepatocellular carcinoma presenting with portal vein tumor thrombus.

Authors:  Kazuyuki Hanajiri; Hiroshi Mitsui; Toshiyuki Maruyama; Yuji Kondo; Shuichiro Shiina; Masao Omata; Keiichi Nakagawa
Journal:  J Gastroenterol       Date:  2005-10       Impact factor: 7.527

3.  FDG PET for discrimination between tumor extension and blood thrombus as a cause for portal vein thrombosis in hepatocellular carcinoma: important role in exclusion of transplant candidacy.

Authors:  Jelica Kurtovic; Hans Van Der Wall; Stephen M Riordan
Journal:  Clin Nucl Med       Date:  2005-06       Impact factor: 7.794

4.  Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein.

Authors:  Iwao Ikai; Etsuro Hatano; Suguru Hasegawa; Hideaki Fujii; Kojiro Taura; Naoki Uyama; Yasuyuki Shimahara
Journal:  J Am Coll Surg       Date:  2006-01-20       Impact factor: 6.113

5.  Detection of tumour thrombus by 18F-FDG-PET/CT imaging.

Authors:  Peter Lai; Jamshed B Bomanji; Shahid Mahmood; Nagesh Nagabhushan; Rizwan Syed; Sveto Gacinovic; Siow M Lee; Peter J Ell
Journal:  Eur J Cancer Prev       Date:  2007-02       Impact factor: 2.497

6.  Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma.

Authors:  Satoru Seo; Etsuro Hatano; Tatsuya Higashi; Tadashi Hara; Masaharu Tada; Nobuyuki Tamaki; Keiko Iwaisako; Iwao Ikai; Shinji Uemoto
Journal:  Clin Cancer Res       Date:  2007-01-15       Impact factor: 12.531

7.  The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients.

Authors:  Sung Hoon Yang; Kyung-Suk Suh; Hae Won Lee; Eung-Ho Cho; Jai Young Cho; Yong Beom Cho; Nam-Joon Yi; Kuhn Uk Lee
Journal:  Liver Transpl       Date:  2006-11       Impact factor: 5.799

8.  Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection.

Authors:  Etsuro Hatano; Iwao Ikai; Tatsuya Higashi; Satoshi Teramukai; Tatsuo Torizuka; Tsuneo Saga; Hideaki Fujii; Yasuyuki Shimahara
Journal:  World J Surg       Date:  2006-09       Impact factor: 3.352

9.  Hepatocellular carcinoma in Central Europe: prognostic features and survival.

Authors:  M Schöniger-Hekele; C Müller; M Kutilek; C Oesterreicher; P Ferenci; A Gangl
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

10.  The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.

Authors:  L James Wudel; Dominique Delbeke; David Morris; Michael Rice; Mary Kay Washington; Yu Shyr; C Wright Pinson; William C Chapman
Journal:  Am Surg       Date:  2003-02       Impact factor: 0.688

View more
  8 in total

1.  Metabolic restaging of hepatocellular carcinoma using whole-body F-FDG PET/CT.

Authors:  Long Sun; Yong-Song Guan; Wei-Min Pan; Zuo-Ming Luo; Ji-Hong Wei; Long Zhao; Hua Wu
Journal:  World J Hepatol       Date:  2009-10-31

2.  Predictive value of ¹⁸F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma.

Authors:  Myeong Jun Song; Si Hyun Bae; Ie Ryung Yoo; Chung-Hwa Park; Jeong Won Jang; Ho Jong Chun; Byung Gil Choi; Hae Giu Lee; Jong Young Choi; Seung Kew Yoon
Journal:  World J Gastroenterol       Date:  2012-07-07       Impact factor: 5.742

3.  The current role of PET-CT in the characterization of hepatobiliary malignancies.

Authors:  Ginseppe Garcea; Seok Ling Ong; Guy J Maddern
Journal:  HPB (Oxford)       Date:  2009-02       Impact factor: 3.647

4.  Evaluation of biodistribution and antitumor effects of (188)Re-rhk5 in a mouse model of lung cancer.

Authors:  Rui Guo; Sheng Liang; Yufei Ma; Hua Shen; Haoping Xu; Biao Li
Journal:  Oncol Lett       Date:  2011-06-16       Impact factor: 2.967

5.  Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma.

Authors:  Long Sun; Yong-Song Guan; Wei-Ming Pan; Gui-Bing Chen; Zuo-Ming Luo; Ji-Hong Wei; Hua Wu
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

6.  Extensive tumor thrombus of hepatocellular carcinoma in the entire portal venous system detected on fluorodeoxyglucose positron emission tomography computed tomography.

Authors:  Archi Agrawal; Nilendu Purandare; Sneha Shah; Ameya Puranik; Venkatesh Rangarajan
Journal:  Indian J Nucl Med       Date:  2013-01

7.  FDG-Avid Portal Vein Tumor Thrombosis from Hepatocellular Carcinoma in Contrast-Enhanced FDG PET/CT.

Authors:  Xuan Canh Nguyen; Dinh Song Huy Nguyen; Van Tan Ngo; Simone Maurea
Journal:  Asia Ocean J Nucl Med Biol       Date:  2015

8.  Effective inhibition of xenografts of hepatocellular carcinoma (HepG2) by rapamycin and bevacizumab in an intrahepatic model.

Authors:  Lai-Chun Ong; In-Chin Song; Yi Jin; Irene H C Kee; Eeyan Siew; Sidney Yu; Choon-Hua Thng; Hung Huynh; Pierce K H Chow
Journal:  Mol Imaging Biol       Date:  2009-03-28       Impact factor: 3.488

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.